Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 11:2023:9969437.
doi: 10.1155/2023/9969437. eCollection 2023.

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors

Yan Li  1 , Zhen Hong  1 , Shaoquan Li  1 , Songwang Xie  1 , Junyong Wang  1 , Jian Wang  1 , Yongchang Liu  1
Affiliations

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors

Yan Li et al. Dis Markers. .

Retraction in

Abstract

Objective: To investigate the efficacy of butylphthalide combined with edaravone in the treatment of acute ischemic stroke and the effect on serum inflammatory factors.

Methods: One hundred and sixty patients with acute ischemic stroke who attended the neurovascular intervention department of our hospital from May 2020 to June 2022 were enrolled as study subjects for prospective analysis and were equally divided into a control group and an experimental group using the random number table method, with 80 cases in each group. The control group was treated with edaravone injection, while the experimental group was treated with butylphthalide combined with edaravone. The disease was recorded to compare the efficacy, erythrocyte sedimentation rate, homocysteine, serum inflammatory factors including tumor necrosis factor-α, C-reactive protein and interleukin-6 levels, and the incidence of adverse reactions between the two groups.

Results: The total effective rate of treatment in the experimental group was 90.0% (72/80), while that of the control group was 62.5% (50/80), the total effective rate of the experimental group was significantly higher than that of the control group, and the difference was statistically significant (P < 0.05). After treatment, the erythrocyte sedimentation rate, homocysteine level, and serum TNF-α, CRP, and IL-6 levels of patients in the experimental group improved compared with those before treatment, and the degree of improvement was better than that of the control group, and the difference was statistically significant (P < 0.05). After 3 months of treatment, a comparison of the incidence of adverse reactions in the two groups showed no statistically significant difference between the two groups (P > 0.05).

Conclusion: The treatment of acute ischemic stroke with butylphthalide combined with edaravone has positive significance in improving blood circulation regulation and serum inflammatory factor levels and is reliable and worthy of clinical promotion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Li C., Chai A., Gao Y., Qi X., Zheng X. Combination of tetrandrine and 3-n-butylphthalide protects against cerebral ischemia-reperfusion injury via ATF2/TLR4 pathway. Immunopharmacology and Immunotoxicology . 2021;43(6):749–757. doi: 10.1080/08923973.2021.1979036. - DOI - PubMed
    1. Li B., Liu G. Magnetic resonance imaging image segmentation under artificial intelligence neural network for evaluation of the effect of butyphthalide combined with edaravone on neurological function in patients with acute cerebral infarction. Frontiers in Neurorobotics . 2021;15, article 719145 doi: 10.3389/fnbot.2021.719145. - DOI - PMC - PubMed
    1. Liu B., Li Y., Han Y., et al. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke. Phytomedicine . 2021;90, article 153660 doi: 10.1016/j.phymed.2021.153660. - DOI - PubMed
    1. Huang P., He X. Y., Xu M. Effect of argatroban injection on clinical efficacy in patients with acute cerebral infarction: preliminary findings. European Neurology . 2021;84(1):38–42. doi: 10.1159/000512813. - DOI - PubMed
    1. Wang G., Ma D., Wang R. Effect of butylphthalide on serum CRP, PARK7, Effect of butylphthalide on serum CRP, PARK7, NT-3 and neurological function in patients with acute cerebral infarction. American Journal of Translational Research . 2021;13(9):10388–10395. - PMC - PubMed

Publication types